The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.

Meetings  July 2018 Next

Executive Committee 2016

  • President: Prof. Dr Koen Augustyns (University of Antwerp, Belgium)
  • Past President: Prof. Dr Hans Ulrich Stilz (Novo Nordisk A/S, Denmark)
  • Secretary: Dr Jordi Grącia (Almirall, Spain)
  • Treasurer: Dr Pascal George (Independent Scientific Expert & Adviser, France)
  • Member: Dr Yves P. Auberson (Novartis Intitutes for BioMedical Research, Switzerland)
  • Member: Prof. Dr Antonello Mai (Sapienza University of Rome, Italy)
  • Member: Prof. Dr Rui Moreira (University of Lisbon, Portugal)

Executive Committee 2015

  • President: Prof. Dr Koen Augustyns (University of Antwerp, Belgium)
  • Past President: Prof. Dr Hans Ulrich Stilz (Novo Nordisk A/S, Denmark)
  • Secretary: Dr Jordi Grącia (Almirall, Spain)
  • Treasurer: Dr Pascal George (Independent Scientific Expert & Adviser, France)
  • Member: Dr Yves P. Auberson (Novartis Intitutes for BioMedical Research, Switzerland)
  • Member: Dr Phil Jones (European Screening Centre Newhouse, United Kingdom)
  • Member: Prof. Dr Antonello Mai (Sapienza University of Rome, Italy)

Executive Committee 2014

  • President: Dr Hans Ulrich Stilz (Novo Nordisk A/S, Denmark)
  • President Elected: Prof. Dr Koen Augustyns (University of Antwerp, Belgium)
  • Treasurer: Dr Hein Coolen (3v-life Science Innovations, The Netherlands)
  • Member: Prof. Dr Gabriele Costantino (University of Parma, Italy)
  • Member: Pascal George (Independent Scientific Expert & Adviser, France)
  • Member: Dr Jordi Grącia (Almirall, Spain)
  • Member: Dr Phil Jones (European Screening Centre Newhouse, United Kingdom)

Executive Committee 2013

  • President: Dr Hans Ulrich Stilz (Sanofi-Aventis Deutschland, Germany)
  • Past President: Prof. Dr Gerhard Ecker (University of Vienna, Austria)
  • Secretary: Prof. Dr Koen Augustyns (University of Antwerp, Belgium)
  • Treasurer: Dr Hein Coolen (3v-life Science Innovations, The Netherlands)
  • Member: Prof. Dr Gabriele Costantino (University of Parma, Italy)
  • Member: Dr Jordi Grącia (Almirall, Spain)
  • Member: Dr Phil Jones (Allsci Consulting ltd, United Kingdom)

Executive Committee 2012

  • President: Dr Hans Ulrich Stilz (Sanofi-Aventis Deutschland, Germany)
  • Past President: Prof. Dr Gerhard Ecker (University of Vienna, Austria)
  • Secretary: Prof. Dr Koen Augustyns (University of Antwerp, Belgium)
  • Treasurer: Dr Rasmus Prętorius Clausen (University of Copenhagen, Denmark)
  • Member: Dr Hein Coolen (StagePharma, The Netherlands)
  • Member: Prof. Dr Gabriele Costantino (University of Parma, Italy)
  • Member: Dr Phil Jones (ASC, United Kingdom)

Executive Committee 2011

  • President: Prof. Dr Gerhard Ecker (University of Vienna, Austria)
  • President Elected: Dr Hans Ulrich Stilz (Sanofi-Aventis Deutschland, Germany)
  • Secretary: Prof. Dr Koen Augustyns (University of Antwerp, Belgium)
  • Treasurer: Dr Rasmus Prętorius Clausen (University of Copenhagen, Denmark)
  • Member: Dr Hein Coolen (Abbott Healthcare Products BV, The Netherlands)
  • Member: Prof. Dr Gabriele Costantino (University of Parma, Italy)
  • Member: Dr Javier Fernandez (Johnson & Johnson Pharmaceuticals R & D, Spain)

Executive Committee 2009-2010

  • President: Prof. Dr Gerhard Ecker (University of Vienna, Austria)
  • Past President: Prof. Dr Roberto Pellicciari (University of Perugia, Italy)
  • Secretary: Prof. Dr Koen Augustyns (University of Antwerp, Belgium)
  • Treasurer: Dr Rasmus Prętorius Clausen (University of Copenhagen, Denmark)
  • Member: Prof Dr Peter Matyus (Semmelweis University, Hungary)
  • Member: Dr Javier Fernandez (Johnson & Johnson Pharmaceuticals R & D, Spain)
  • Member: Dr Mark Bunnage (Pfizer Global Research & Development, United Kingdom)

Executive Committee 2008

  • President: Prof. Dr Roberto Pellicciari (University of Perugia, Italy)
  • President Elected: Prof. Dr Gerhard Ecker (University of Vienna, Austria)
  • Secretary/Treasurer: Dr Rasmus Prętorius Clausen (University of Copenhagen, Denmark)
  • Member: Dr David Alker (David Alker Associates, United Kingdom)
  • Member: Dr Brigitte Lesur (Institut De Recherches Servier, France)
  • Member: Prof. Dr Peter Matyus (Semmelweis University, Hungary)

Executive Committee 2007

  • President: Prof. Dr Roberto Pellicciari (Universitą di Perugia, Italy)
  • Past-President: Prof. Dr Ferran Sanz (University Pompeu Fabra, Spain)
  • Treasurer: Dr Rasmus Prętorius Clausen (Danish University, Denmark)
  • Secretary: Prof. Dr Gerhard Ecker (University of Vienna, Austria)
  • Member: Dr David Alker (David Alker Associates, United Kingdom)
  • Member: Dr Brigitte Lesur (Institut De Recherches Servier, France)
  • Member: Prof. Peter Matyus (Semmelweis University, Hungary)

Executive Committee 2006

  • President: Prof. Roberto Pellicciari (University of Perugia, Italy)
  • Past-President: Prof. Dr Ferran Sanz (University Pompeu Fabra, Spain)
  • Secretary/Treasurer: Prof. D. Gerhard Ecker (University of Vienna, Austria)
  • Member: Dr David Alker (United Kingdom)
  • Member: Dr Brigitte Lesur (Cephalon France, France)
  • Member: Prof. Peter Matyus (Semmelweis University, Hungary)

Executive Committee 2005

  • President: Prof. Dr Ferran Sanz (University Pompeu Fabra, Spain)
  • President Elect: Prof. Roberto Pellicciari (University of Perugia, Italy)
  • Secretary: Prof. Dr Gerhard Ecker (University of Vienna, Austria)
  • Treasurer: Dr Wolfgang Froestl (Novartis Pharma AG, Switzerland)
  • Additional Member: Dr David Alker (Pfizer Global Research and Development, United Kingdom)
  • Additional Member: Dr Brigitte Lesur (Cephalon France, France)
  • Additional Member: Prof. Peter Matyus (Semmelweis University, Hungary)

Executive Committee 2002-2004

  • Chairman: Prof. Dr Ferran Sanz (University Pompeu Fabra, Spain)
  • Vice-Chairman: Dr Edmond Differding (UCB Pharma, Belgium)
  • Past-Chairman:  Prof. Dr Henk Timmerman (Vrije Universiteit Amsterdam, The Netherlands)
  • Secretary: Prof. Dr Gerhard Ecker (University of Vienna, Austria)
  • Treasurer: Dr Wolfgang Froestl (Novartis Pharma AG, Switzerland)
  • International Liaison Officer: Dr Derek Buckle (DRB Associates, United Kingdom)
  • Long-Term Planning Officer: Prof. Dr Roberto Pellicciari (University of Perugia, Italy)

M T W T F S S
25 26 27 28 29 30 01
02 03 04 05 06 07 08
09 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31 01 02 03 04 05
All events   |  Future events

Job portal

27/04/2018
MsC student or PhD internship, KU Leuven: Cellular and Molecular Medicine, Leuven, Belgium
read more


20/04/2017
Medicinal / Synthetic Organic Chemists, Concept Life Sciences: Drug Discovery, Sandwich, Kent, United Kingdom
read more


Job portal page

Follow us on Facebook

Follow us on Twitter

Follow us on LinkedIn

Follow us on Instagram

ChemBridgeBoehringer IngelheimNovartisProf Dr W. Th. Nauta FoundationPfizerServierRoche
 Prous Institute for Biomedical ResearchUCBJanssen R&DBayerMerck